机构

• 上海药物研究所 [6]
• 合肥物质科学研究院 [1]

采集方式

• OAI收割 [7]

内容类型

• 期刊论文 [7]

发表日期

• 2023 [1]
• 2022 [1]
• 2018 [1]
• 2016 [2]
• 2015 [2]

学科主题

筛选

浏览/检索结果: 共7条，第1-7条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Photophysical Exploration of Alectinib and Rilpivirine: Insights from Theory and Experiment 期刊论文  OAI收割 MOLECULES, 2023, 卷号: 28, 期号: 16, 页码: 16 作者:  Zhang, Chun;  Yang, Yuting;  Gan, Suya;  Ren, Aimin;  Zhou, Yu-Bo   |  收藏  |  浏览/下载：8/0  |  提交时间：2023/10/17 fluorescence imaging  Alectinib  Rilpivirine  quantum chemistry   Novel HIVEP1-ALK fusion in a patient with lung adenocarcinoma demonstrating sensitivity to alectinib: a case report 期刊论文  OAI收割 TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 卷号: 11 作者:  Gu, Xiaodong;  Wang, Wenxian;  Wu, Wei;  Zhang, Yiping;  Shao, Lan   |  收藏  |  浏览/下载：72/0  |  提交时间：2022/12/22 Non-small cell lung cancer (NSCLC)  HIVEP1-ALK  alectinib  intergenic region (IGR)  case report   Pharmacologic characterization of CT-711, a novel dual inhibitor of ALK and c-Met 期刊论文  OAI收割 AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 卷号: 8, 期号: 8, 页码: 1541-1550 作者:  Wang, Lei;  Gao, Mingzhao;  Tong, Mengya;  Xie, Chengying;  He, Ye   |  收藏  |  浏览/下载：121/0  |  提交时间：2019/01/08 CT-711  ALK  c-Met  crizotinib  antitumor activity  pharmacokinetics   Metabolism-based structure optimization: Discovery of a potent and orally available tyrosine kinase ALK inhibitor bearing the tetracyclic benzo[b]carbazolone core 期刊论文  OAI收割 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 卷号: 26, 期号: 22, 页码: 5399-5402 作者:  Han, Mei;  Wang, Chengyan;  Ji, Yinchun;  Song, Zilan;  Xing, Li   |  收藏  |  浏览/下载：66/0  |  提交时间：2019/01/08 EML4-ALK kinase  Oxidative metabolism  Benzo[b]carbazolone  hERG  Antitumor activity   An orally available tyrosine kinase ALK and RET dual inhibitor bearing the tetracyclic benzo[b]carbazolone core 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 卷号: 118, 页码: 244-249 作者:  Song, Zilan;  Xia, Zongjun;  Ji, Yinchun;  Xing, Li;  Gao, Yinglei   |  收藏  |  浏览/下载：70/0  |  提交时间：2019/01/08 Benzo[b]carbazolones  ALK inhibitors  RET kinase  Antiresistance  Non-small-cell lung cancer  Preclinical study   Novel tetracyclic benzo[b]carbazolones as highly potent and orally bioavailable ALK inhibitors: Design, synthesis, and structure-activity relationship study 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 卷号: 105, 页码: 39-56 作者:  Jiang, Xiaolong;  Zhou, Ji;  Ai, Jing;  Song, Zilan;  Peng, Xia   |  收藏  |  浏览/下载：60/0  |  提交时间：2019/01/08 Benzo[b]carbazolones  ALK inhibitors  Anti-cancer  Anti-resistance  Non-small-cell lung cancer   Alectinib: a novel second generation anaplastic lymphoma kinase (ALK) inhibitor for overcoming clinically-acquired resistance 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2015, 卷号: 5, 期号: 1, 页码: 34-37 作者:  Song, Zilan;  Wang, Meining;  Zhang, Ao   |  收藏  |  浏览/下载：55/0  |  提交时间：2019/01/08 Tyrosine anaplastic lymphoma kinase  Alectinib  Crizotinib  Non-suaall cell lung cancer  Resistance ALK mutations  EML4-ALK